PCR-based comprehensive genomic profiling (PCR-CGP): Feasibility from > 20,000 tumor tissue specimens (TTS) and predicted impact on actionable biomarker identification versus hybrid capture (H)CGP and plasma (P)-CGP.

PCR-based comprehensive genomic profiling (PCR-CGP): Feasibility from > 20,000 tumor tissue specimens (TTS) and predicted impact on actionable biomarker identification versus hybrid capture (H)CGP and plasma (P)-CGP. Article

Web of Science: 000560368301465

Rhodes, Dan; Hovelson, Daniel H.; Suga, Jennifer Marie; Anderson, Daniel M.; Dees, Elizabeth Claire; Koh, Han A.; Burkard, Mark E.; Khatri, Jamil; Safa, Malek M.; Matrana, Marc Ryan; Yang, Eddy Shih-Hsin; Menter, Alex R.; Parsons, Benjamin Marshall; Slim, Jennifer Nadine; Falkner, Jayson; Reeder, Travis; Vakil, Hana; Kwiatkowski, Kat; Johnson, Bryan; Tomlins, Scott A.